Homepage>Company>Media>Company news>2016>Viriom Announces Receipt of Funding from the Skolkovo Foundation, ChemRar and Torrey Pines Investment to Develop Elpida®, a Novel Preventive and Long-acting Treatment of HIV/AIDS
Viriom Announces Receipt of Funding from the Skolkovo Foundation, ChemRar and Torrey Pines Investment to Develop Elpida®, a Novel Preventive and Long-acting Treatment of HIV/AIDS